Zhiping Wan

643 total citations · 1 hit paper
19 papers, 489 citations indexed

About

Zhiping Wan is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Zhiping Wan has authored 19 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Cancer Research. Recurrent topics in Zhiping Wan's work include Nanoplatforms for cancer theranostics (6 papers), MicroRNA in disease regulation (5 papers) and Extracellular vesicles in disease (4 papers). Zhiping Wan is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), MicroRNA in disease regulation (5 papers) and Extracellular vesicles in disease (4 papers). Zhiping Wan collaborates with scholars based in China, United States and Australia. Zhiping Wan's co-authors include Chun Luo, Chunlin Li, Fen Xu, Xijian Liu, Jie Lü, Guoying Deng, Huairui Chen, Yunfeng Shen, Mengyin Cai and Wei Wang and has published in prestigious journals such as Chemical Engineering Journal, Journal of Colloid and Interface Science and Nanoscale.

In The Last Decade

Zhiping Wan

19 papers receiving 487 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis

2023 76 citations Yunfeng Shen, Minxuan Xu et al. Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhiping Wan China	9	217	175	172	117	81	19	489
Guoqing Zuo China	14	181 0.8×	125 0.7×	156 0.9×	73 0.6×	93 1.1×	36	577
Weixi Jiang China	15	137 0.6×	54 0.3×	261 1.5×	104 0.9×	101 1.2×	22	574
Meng-jun Qiu China	13	174 0.8×	65 0.4×	188 1.1×	111 0.9×	70 0.9×	28	535
Chunhui Cui China	15	319 1.5×	225 1.3×	103 0.6×	51 0.4×	31 0.4×	42	578
Lingxiao Zhang China	8	359 1.7×	70 0.4×	135 0.8×	44 0.4×	53 0.7×	15	595
Wenwen Chai China	10	232 1.1×	124 0.7×	85 0.5×	28 0.2×	32 0.4×	20	453

Countries citing papers authored by Zhiping Wan

Since Specialization

Citations

This map shows the geographic impact of Zhiping Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiping Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiping Wan more than expected).

Fields of papers citing papers by Zhiping Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiping Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiping Wan. The network helps show where Zhiping Wan may publish in the future.

Co-authorship network of co-authors of Zhiping Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiping Wan. A scholar is included among the top collaborators of Zhiping Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiping Wan. Zhiping Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Wan, Zhiping, Lili Wu, Xiang Cai, et al.. (2025). CiR-EIS alleviates metabolic dysfunction-associated steatohepatitis by modulating macrophage polarization involving the miR-548m/IGF1 axis. Clinical Nutrition. 50. 104–116. 1 indexed citations

Wan, Zhiping, Xiaoxiao Cai, Haoqi Chen, et al.. (2025). Hepatocyte-derived Pumilio1-enriched exosomes inhibit HSC activation by suppressing tropomyosin-4 translation. Hepatology Communications. 9(8). 1 indexed citations

Wan, Zhiping, et al.. (2024). MicroRNA-411-5p alleviates lipid deposition in metabolic dysfunction-associated steatotic liver disease by targeting the EIF4G2/FOXO3 axis. Cellular and Molecular Life Sciences. 81(1). 398–398. 3 indexed citations

Wan, Zhiping, et al.. (2024). Dopamine Inhibits the Expression of Hepatitis B Virus Surface and e Antigens by Activating the JAK/STAT Pathway and Upregulating Interferon-stimulated Gene 15 Expression. Journal of Clinical and Translational Hepatology. 12(5). 443–456. 2 indexed citations

Guo, Xin, et al.. (2024). Circularly Polarized Antenna Array Using Filtering Phase Shifting Theory. Progress In Electromagnetics Research Letters. 116. 9–16. 1 indexed citations

Wan, Zhiping, et al.. (2023). Identification of angiogenesis‐related genes signature for predicting survival and its regulatory network in glioblastoma. Cancer Medicine. 12(16). 17445–17467. 7 indexed citations

Shen, Yunfeng, Minxuan Xu, Wei Wang, et al.. (2023). SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis. Metabolism. 146. 155657–155657. 76 indexed citations breakdown →

Wang, Wei, et al.. (2023). Pioglitazone-Enhanced Brown Fat Whitening Contributes to Weight Gain in Diet-Induced Obese Mice. Experimental and Clinical Endocrinology & Diabetes. 131(11). 595–604. 3 indexed citations

Wan, Zhiping, et al.. (2022). M2 macrophage-derived exosomal microRNA-411-5p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model. iScience. 25(7). 104597–104597. 36 indexed citations

10.

Xiang, Dingding, Yangyang Cui, Zhiping Wan, et al.. (2022). Study on swelling, compression property and degradation stability of PVA composite hydrogels for artificial nucleus pulposus. Journal of the mechanical behavior of biomedical materials. 136. 105496–105496. 16 indexed citations

11.

Wang, Xingyan, Zhiping Wan, Chunlin Li, et al.. (2022). Defective Cu2-xSe crystals for ultrasound-enhanced CDT of tumor therapy. Ceramics International. 48(23). 34564–34570. 7 indexed citations

12.

Wan, Zhiping, Jianwei Li, Xiaogang Bi, et al.. (2022). Diagnostic Potential of microRNAs in Extracellular Vesicles Derived from Bronchoalveolar Lavage Fluid for Pneumonia—A Preliminary Report. Cells. 11(19). 2961–2961. 6 indexed citations

13.

Wang, Xiang, Chunlin Li, Xingyan Wang, et al.. (2022). Mutual promotion of oxidative stress amplification and calcium overload by degradable spatially selective self-cascade catalyst for synergistic tumor therapy. Chemical Engineering Journal. 432. 134438–134438. 41 indexed citations

14.

Wan, Zhiping, Chunlin Li, Jun Qian, et al.. (2021). Accurately Controlled Delivery of Temozolomide by Biocompatible UiO-66-NH2 Through Ultrasound to Enhance the Antitumor Efficacy and Attenuate the Toxicity for Treatment of Malignant Glioma. International Journal of Nanomedicine. Volume 16. 6905–6922. 29 indexed citations

15.

Liu, Xijian, Yang Fu, Chunlin Li, et al.. (2021). A biodegradable “Nano-donut” for magnetic resonance imaging and enhanced chemo/photothermal/chemodynamic therapy through responsive catalysis in tumor microenvironment. Journal of Colloid and Interface Science. 608(Pt 1). 344–354. 69 indexed citations

16.

Wan, Zhiping, Yining Wang, Jun Qian, et al.. (2020). Facile Interfacial Synthesis of Densely Spiky Gold Nano-Chestnuts With Full Spectral Absorption for Photothermal Therapy. Frontiers in Bioengineering and Biotechnology. 8. 599040–599040. 1 indexed citations

17.

Ren, Qilong, Kuikun Yang, Rujia Zou, et al.. (2019). Biodegradable hollow manganese/cobalt oxide nanoparticles for tumor theranostics. Nanoscale. 11(47). 23021–23026. 36 indexed citations

18.

Chen, Huairui, Jun Qian, Lei Zhang, et al.. (2019). A novel lncRNA‐LINC01116 regulates tumorigenesis of glioma by targeting VEGFA. International Journal of Cancer. 146(1). 248–261. 71 indexed citations

19.

Zhang, Lei, Lili Xia, Heng Jiang, et al.. (2017). Differential Expression of Circular RNAs in Glioblastoma Multiforme and Its Correlation with Prognosis. Translational Oncology. 10(2). 271–279. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guoqing Zuo Breakdown of academic impact, for papers by Weixi Jiang Breakdown of academic impact, for papers by Meng-jun Qiu Breakdown of academic impact, for papers by Chunhui Cui Breakdown of academic impact, for papers by Lingxiao Zhang Breakdown of academic impact, for papers by Wenwen Chai